Qlaira filmom obložene tablete
Name | Qlaira filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-182628999 |
Active Substance | estradiolvalerat dienogest |
Composition | Svaki kartonski ovitak oblika novčanika (28 filmom obloženih tableta) sadrži tablete ovim redoslijedom: 2 tamnožute tablete s 3 mg estradiolvalerata 5 srednjecrvenih tableta s 2 mg estradiolvalerata i 2 mg dienogesta 17 svijetložutih tableta s 2 mg estradiolvalerata i 3 mg dienogesta 2 tamnocrvene tablete s 1 mg estradiolvalerata 2 bijele tablete koje ne sadrže djelatnu tvar |
Pharmaceutical Form | filmom obložena tableta |
Manufacturer | Bayer Weimar GmbH und Co. KG., Weimar, Njemačka
Bayer AG, Berlin, Njemačka |
Marketing Authorisation Holder | Bayer d.o.o., Radnička cesta 80, Zagreb, Hrvatska |
Marketing Authorisation Date | 15.02.2018 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/850 |
Registration Number | 381-12-01/30-18-03 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ponovljivi recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | G03AB08 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Lista provjere za liječnike (verzija 1) Popratno pismo za liječnike Popratno pismo za ljekarnike |
Educational materials for patients / caregivers |
Važne informacije za korisnicu (verzija 1) |